miR-32 inhibits proliferation, epithelial–mesenchymal transition, and metastasis by targeting TWIST1 in non-small-cell lung cancer cells
Lei Li,1,* Dapeng Wu2,* 1Department of Pneumology, 2Department of Radiotherapy, Huaihe Hospital of Henan University, Kaifeng, Henan, People’s Republic of China *These authors contributed equally to this work Background: By analyzing published microRNA microarray studies, miR-32...
Main Authors: | Li L, Wu DP |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-03-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/mir-32-inhibits-proliferation-epithelialndashmesenchymal-transition-an-peer-reviewed-article-OTT |
Similar Items
-
Diabetic nephropathy execrates epithelial-to-mesenchymal transition (EMT) via miR-2467-3p/Twist1 pathway
by: Yan Xu, et al.
Published: (2020-05-01) -
miR-1271 inhibits growth, invasion and epithelial–mesenchymal transition by targeting ZEB1 in ovarian cancer cells
by: Jiao Y, et al.
Published: (2019-08-01) -
Epithelial mesenchymal transition in urothelial carcinoma: Twist in the tale
by: Purnima Paliwal, et al.
Published: (2012-01-01) -
MicroRNA miR-509-3p inhibit metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma
by: Huiming Zhang, et al.
Published: (2021-01-01) -
Anti-Cancer Effects of Glaucarubinone in the Hepatocellular Carcinoma Cell Line Huh7 via Regulation of the Epithelial-to-Mesenchymal Transition-Associated Transcription Factor Twist1
by: Jihye Seo, et al.
Published: (2021-02-01)